Clinical trial
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
NCT03803475 is registered in ClinicalTrials.gov with Thomas Hope as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients
- Lead sponsor
- Thomas Hope
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 11, 2018
- Completion date
- August 25, 2020
- Enrollment
- 485 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer